Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03527199 · ClinicalTrials.gov registry record
Prostate Cancer Patients With Biochemical Recurrence
A clinical trial of Patients With Prostate Cancer, sponsored by Medhat Osman.
- Completed
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT03527199: Completed study of Patients With Prostate Cancer, sponsored by Medhat Osman.
NCT03527199 is a study of Patients With Prostate Cancer that has completed, run by Medhat Osman. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03527199, a study of Patients With Prostate Cancer, has completed, sponsored by Medhat Osman.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of detection rate of 18F-Fluciclovine compared to current standard of care imaging techniques within 30 days of the standard of care imaging study and a 6 month phone follow-up
Primary Outcome
Detection rate of 18F- Fluciclovine PET/CT will be compared to current standard of care imaging with or without 18F-NaF PET/CT based on all available clinical follow up data including histological reference standard when biopsy of suspected lesion(s) is performed.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC)
Study Locations (1)
Missouri
- John Cochran VA Medical Center St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2023-04-10 |
What the finished NCT03527199 record still lists
NCT03527199 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 1 condition, with Patients With Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC) is the first listed.
NCT03527199 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03527199 about?
NCT03527199 is a clinical study titled "Prostate Cancer Patients With Biochemical Recurrence". Evaluation of detection rate of 18F-Fluciclovine compared to current standard of care imaging techniques within 30 days of the standard of care imaging study and a 6 month phone follow-up
What is the current status of trial NCT03527199?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2018-12-18. Estimated completion is 2023-04-10.
What conditions does trial NCT03527199 study?
This clinical trial studies the following conditions: Patients With Prostate Cancer.
What interventions are being tested in trial NCT03527199?
The interventions under investigation include: Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03527199?
This trial is sponsored by Medhat Osman, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03527199 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI